Electrospinning of silica nanoparticles-entrapped nanofibers for sustained Gentamicin (cas 1403-66-3) release
-
Add time:09/09/2019 Source:sciencedirect.com
Sustained antibiotic release is important to prevent the infections after surgical treatments such as guided tissue regeneration (GTR). Electrospinning provides a simple way to fabricate nanofibers for drug delivery. In this study, a simple method to achieve sustained antibiotic release by introducing mesoporous silica nanoparticles (MSNs)with electrospinning is developed. The nanoparticles entrapped nanofibers (MSNs-PCL) were successfully fabricated, and a sustained release of Gentamicin (cas 1403-66-3) was demonstrated. The gentamicin loaded MSNs-PCL showed strong antimicrobial effects against E. coli, indicated the sustained release behavior and the retained bioactivity. The MSNs-PCL synthesized by electrospinning method shows great potential for biomedical applications such as fabricating GTR membranes.
We also recommend Trading Suppliers and Manufacturers of Gentamicin (cas 1403-66-3). Pls Click Website Link as below: cas 1403-66-3 suppliers
Prev:Microbicidal Gentamicin (cas 1403-66-3)-alginate hydrogels
Next:Research paperEvaluation of collagen/hydroxyapatite electrospun layers loaded with vancomycin, Gentamicin (cas 1403-66-3) and their combination: Comparison of release kinetics, antimicrobial activity and cytocompatibility) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Research paperEvaluation of collagen/hydroxyapatite electrospun layers loaded with vancomycin, Gentamicin (cas 1403-66-3) and their combination: Comparison of release kinetics, antimicrobial activity and cytocompatibility09/10/2019
- Microbicidal Gentamicin (cas 1403-66-3)-alginate hydrogels09/08/2019
- Synthesis of Gentamicin (cas 1403-66-3)-grafted-chitosan with improved solubility and antibacterial activity09/07/2019
- Controllable delivery from Gentamicin (cas 1403-66-3) loaded polycaprolactone/grafted silica nanoparticles composite mats09/06/2019
- Improving Gentamicin (cas 1403-66-3) B and Gentamicin (cas 1403-66-3) C1a production by engineering the glycosyltransferases that transfer primary metabolites into secondary metabolites biosynthesis09/05/2019
- Original articleEffect of Withania somnifera on Gentamicin (cas 1403-66-3) induced renal lesions in rats09/04/2019
- Intratympanic mixture Gentamicin (cas 1403-66-3) and dexamethasone versus dexamethasone for unilateral Meniere's disease09/03/2019
- Overproduction of Gentamicin (cas 1403-66-3) B in industrial strain Micromonospora echinospora CCTCC M 2018898 by cloning of the missing genes genR and genS09/02/2019
- Original ArticleStandard-dose Gentamicin (cas 1403-66-3) does not increase risk of patent ductus arteriosus09/01/2019


